To further explore the possible links between P2RY8 reduction and disease pathogenesis, SLE patients were divided into those with high or low expression of P2RY8 in B cells compared with normal expression in healthy donors, and clinical and immunological features were then compared between those two groups. This evidence concerns the gene P2RY8 and systemic lupus erythematosus.